518 related articles for article (PubMed ID: 12940804)
21. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
22. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs.
Schulman EA; Dermott KF
Headache; 2003; 43(7):729-33. PubMed ID: 12890127
[TBL] [Abstract][Full Text] [Related]
23. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
[TBL] [Abstract][Full Text] [Related]
24. Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
[TBL] [Abstract][Full Text] [Related]
25. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
26. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine.
Aurora SK; Barrodale PM; McDonald SA; Jakubowski M; Burstein R
Headache; 2009 Jul; 49(7):1001-4. PubMed ID: 19438735
[TBL] [Abstract][Full Text] [Related]
27. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
Gallagher RM; Dennish G; Spierings EL; Chitra R
Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
[TBL] [Abstract][Full Text] [Related]
28. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
Diamond S; Elkind A; Jackson RT; Ryan R; DeBussey S; Asgharnejad M
Arch Fam Med; 1998; 7(3):234-40. PubMed ID: 9596457
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Calhoun AH; Ford S
Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
[TBL] [Abstract][Full Text] [Related]
30. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
Pini LA; Fabbri L; Cavazzuti L
Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
[TBL] [Abstract][Full Text] [Related]
32. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
33. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
Lipton RB; Stewart WF; Cady R; Hall C; O'Quinn S; Kuhn T; Gutterman D
Headache; 2000; 40(10):783-91. PubMed ID: 11135021
[TBL] [Abstract][Full Text] [Related]
34. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
35. WITHDRAWN: Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD002915. PubMed ID: 22336784
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial.
Cerbo R; Centonze V; Grazioli I; Tavolato B; Trenti T; Uslenghi C; Sternieri E
Eur J Neurol; 2005 Oct; 12(10):759-67. PubMed ID: 16190913
[TBL] [Abstract][Full Text] [Related]
37. Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine.
Galeotti N; Ghelardini C; Grazioli I; Uslenghi C
Pharmacol Res; 2002 Sep; 46(3):245-50. PubMed ID: 12220967
[TBL] [Abstract][Full Text] [Related]
38. Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study.
Silberstein S; McDonald SA; Goldstein J; Aurora S; Lener SE; White J; Runken MC; Saiers J; Derosier F; Lipton RB
Cephalalgia; 2014 Apr; 34(4):268-79. PubMed ID: 24108307
[TBL] [Abstract][Full Text] [Related]
39. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
40. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
Kostic MA; Gutierrez FJ; Rieg TS; Moore TS; Gendron RT
Ann Emerg Med; 2010 Jul; 56(1):1-6. PubMed ID: 20045576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
